Pathophysiology and Management of the Burn Scar

Clinics in Plastic Surgery

Volumn 36, Issue 4, 2009, Pages 661-674

  Ladak, Adil ^a   Tredget, Edward E ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Burns; Fibroproliferative disorder; Hypertrophic scar; Outcome; Treatment

Indexed keywords

ALPHA2B INTERFERON; EPIDERMAL GROWTH FACTOR; FIBRINOGEN; INTERFERON; PLATELET DERIVED GROWTH FACTOR; SILICON; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA;

ANTIINFLAMMATORY ACTIVITY; BLOOD CLOTTING; BONE MARROW CELL; BURN SCAR; CLINICAL TRIAL; COMPRESSION GARMENT; CYTOKINE PRODUCTION; FIBRIN FORMATION; HUMAN; HYPERTROPHIC SCAR; IMMUNE RESPONSE; NONHUMAN; PATHOGENESIS; PROTEIN FUNCTION; REVIEW; RISK FACTOR; SKIN BLOOD FLOW; SKIN EXAMINATION; SKIN FIBROSIS; SKIN INFLAMMATION; SKIN INJURY;

BONE MARROW CELLS; BURNS; CICATRIX; CICATRIX, HYPERTROPHIC; FIBROSIS; HUMANS; INFLAMMATION; TREATMENT OUTCOME;

EID: 70349327673     PISSN: 00941298     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cps.2009.05.014     Document Type: Review

References (90)

1. Tredget E.E., Nedelec B., Scott P.G., et al. Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy. Surg Clin North Am 77 3 (1997) 701-730
2. Tredget E.E., Nedelec B., and Ghahary A. The molecular biology of wound healing following thermal injury: the role of fibrogenic and antifibrogenic growth factors. In: Lorente J.A., and Esteban A. (Eds). Critical care of the burn patient (1998), Springer-Verlag
3. Scott P.G., Ghahary A., Chambers M., et al. Biological basis of hypertrophic scarring. Advances in structural biology vol. 3 (1996), JAI Press Incorporated, Greenwich (CT)
4. Kozak L, Bacon W, Krzyzanowski M, et al. Vital and health statistisitics. In: Office GP, editor. 1998
5. Rudolph R. Wide-spread scars, hypertrophic scars, and keloids. Clin Plast Surg 14 2 (1987) 253-260
6. Tredget E.E. Pathophysiology and treatment of fibroproliferative disorders following thermal injury. Ann N Y Acad Sci 888 (1999) 165-182
7. Deitch E.A., Wheelahan T.M., Rose M.P., et al. Hypertrophic burn scars: analysis of variables. J Trauma 23 10 (1983) 895-898
8. Mosmann T.R., and Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7 (1989) 145-173
9. Kelly J.L., O'Suilleabhain C.B., Soberg C.C., et al. Severe injury triggers antigen-specific T-helper cell dysfunction. Shock 12 1 (1999) 39-45
10. Romagnani S. Biology of human TH1 and TH2 cells. J Clin Immunol 15 3 (1995) 121-129
11. Romagnani S. Th1 and Th2 in human diseases. Clin Immunol Immunopathol 80 (1996) 225-235
12. Fiorentino D.F., Bond M.W., and Mosmann T.R. Two types of mouse T-helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170 6 (1989) 2081-2095
13. Wang R., Ghahary A., Shen Y.J., et al. Human dermal fibroblasts produce nitric oxide and express both constitutive and inducible nitric oxide synthase isoforms. J Invest Dermatol 106 3 (1996) 419-427
14. Caligaris-Cappio F., Bertero M.T., Converso M., et al. Circulating levels of soluble CD30, a marker of cells producing Th2-type cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity. Clin Exp Rheumatol 13 3 (1995) 339-343
15. Needleman B.W., Wigley F.M., and Stair R.W. Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma. Arthritis Rheum 35 1 (1992) 67-72
16. Horgan A.F., Mendez M.V., O'Riordain D.S., et al. Altered gene transcription after burn injury results in depressed T-lymphocyte activation. Ann Surg 220 3 (1994) 342-351 [discussion: 51-2]
17. O'Sullivan S.T., Lederer J.A., Horgan A.F., et al. Major injury leads to predominance of the T-helper 2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 222 4 (1995) 482-490 [discussion: 90-2]
18. Kilani R.T., Delehanty M., Shankowsky H.A., et al. Fluorescent-activated cell-sorting analysis of intracellular interferon-gamma and interleukin-4 in fresh and frozen human peripheral blood T-helper cells. Wound Repair Regen 13 4 (2005) 441-449
19. Tredget E., Yang L., Delehanty M., et al. Polarized T-helper cells Th2 cytokine production in patients with hypertrophic scar following thermal injury. J Interferon Cytokine Res 26 3 (2005) 179-189
20. Wang J., Jiao H., Stewart T.L., et al. Increased TGF-beta-producing CD4+ T-lymphocytes in postburn patients and their potential interaction with dermal fibroblasts in hypertrophic scarring. Wound Repair Regen 15 4 (2007) 530-539
21. Armour A., Scott P.G., and Tredget E.E. Cellular and molecular pathology of HTS: basis for treatment. Wound Repair Regen 15 1 (2007) S6-17
22. Werner S., and Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 83 3 (2003) 835-870
23. Liu C.J., Tahara S., and Gao S. Phosphorylation of extracellular signal-regulated protein kinase in cultured keloid fibroblasts when stimulated by platelet-derived growth factor BB. Scand J Plast Reconstr Surg Hand Surg 37 6 (2003) 321-324
24. Abdollahi A., Li M., Ping G., et al. Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. J Exp Med 201 6 (2005) 925-935
25. Roberts A.B. Molecular and cell biology of TGF-beta. Miner Electrolyte Metab 24 (1998) 111-119
26. Cutroneo K.R. TGF-beta-induced fibrosis and SMAD signaling: oligo decoys as natural therapeutics for inhibition of tissue fibrosis and scarring. Wound Repair Regen 15 1 (2007) S54-S60
27. Ignotz R.A., and Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261 9 (1986) 4337-4345
28. Sporn M.B., Roberts A.B., Wakefield L.M., et al. Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 105 3 (1987) 1039-1045
29. Varga J., Rosenbloom J., and Jimenez S.A. Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem J 247 3 (1987) 597-604
30. Kahari V.M., Larjava H., and Uitto J. Differential regulation of extracellular matrix proteoglycan (PG) gene expression. Transforming growth factor-beta 1 up-regulates biglycan (PGI), and versican (large fibroblast PG) but down-regulates decorin (PGII) mRNA levels in human fibroblasts in culture. J Biol Chem 266 16 (1991) 10608-10615
31. Holderfield M.T., and Hughes C.C. Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-beta in vascular morphogenesis. Circ Res 102 6 (2008) 637-652
32. Edwards D.R., Murphy G., Reynolds J.J., et al. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6 7 (1987) 1899-1904
33. Overall C.M., Wrana J.L., and Sodek J. Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. J Biol Chem 264 3 (1989) 1860-1869
34. Bock O., Yu H., Zitron S., et al. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars. Acta Derm Venereol 85 3 (2005) 216-220
35. Grotendorst G.R. Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev 8 3 (1997) 171-179
36. Leask A., and Abraham D.J. TGF-beta signaling and the fibrotic response. FASEB J 18 7 (2004) 816-827
37. Khoo Y.T., Ong C.T., Mukhopadhyay A., et al. Upregulation of secretory connective tissue growth factor (CTGF) in keratinocyte-fibroblast coculture contributes to keloid pathogenesis. J Cell Physiol 208 2 (2006) 336-343
38. Colwell A.S., Phan T.T., Kong W., et al. Hypertrophic scar fibroblasts have increased connective tissue growth factor expression after transforming growth factor-beta stimulation. Plast Reconstr Surg 116 5 (2005) 1387-1390 [discussion: 91-2]
39. Tredget E.E., Shankowsky H.A., Pannu R., et al. Transforming growth factor-beta in thermally injured patients with hypertrophic scars: effects of interferon alpha-2b. Plast Reconstr Surg 102 5 (1998) 1317-1328 [discussion: 29-30]
40. Wang R., Ghahary A., Shen Q., et al. Hypertrophic scar tissues and fibroblasts produce more transforming growth factor-beta1 mRNA and protein than normal skin and cells. Wound Repair Regen 8 2 (2000) 128-137
41. Ghahary A., Shen Y.J., Nedelec B., et al. Interferons gamma and alpha-2b differentially regulate the expression of collagenase and tissue inhibitor of metalloproteinase-1 messenger RNA in human hypertrophic and normal dermal fibroblasts. Wound Repair Regen 3 2 (1995) 176-184
42. Scott P.G., Dodd C.M., Tredget E.E., et al. Immunohistochemical localization of the proteoglycans decorin, biglycan and versican and transforming growth factor-beta in human postburn hypertrophic and mature scars. Histopathology 26 5 (1995) 423-431
43. Yamaguchi Y., Mann D.M., and Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 346 6281 (1990) 281-284
44. Hausser H., Groning A., Hasilik A., et al. Selective inactivity of TGF-beta/decorin complexes. FEBS Lett 353 3 (1994) 243-245
45. Scott P.G., Dodd C.M., Ghahary A., et al. Fibroblasts from postburn hypertrophic scar tissue synthesize less decorin than normal dermal fibroblasts. Clin Sci (Lond) 94 5 (1998) 541-547
46. Ghahary A., Shen Y.J., Nedelec B., et al. Enhanced expression of mRNA for insulin-like growth factor-1 in post-burn hypertrophic scar tissue and its fibrogenic role by dermal fibroblasts. Mol Cell Biochem 148 1 (1995) 25-32
47. Ghahary A., Shen Q., Shen Y.J., et al. Induction of transforming growth factor beta 1 by insulin-like growth factor-1 in dermal fibroblasts. J Cell Physiol 174 3 (1998) 301-309
48. Ghahary A., Shen Y.J., Nedelec B., et al. Collagenase production is lower in postburn hypertrophic scar fibroblasts than in normal fibroblasts and is reduced by insulin-like growth factor-1. J Invest Dermatol 106 3 (1996) 476-481
49. Ghahary A., Shen Y.J., Wang R., et al. Expression and localization of insulin-like growth factor-1 in normal and postburn hypertrophic scar tissue in human. Mol Cell Biochem 183 (1998) 1-9
50. Scott P.G., Ghahary A., and Tredget E.E. Molecular and cellular aspects of fibrosis following thermal injury. Hand Clin 16 2 (2000) 271-287
51. Yang L., Scott P.G., Giuffre J., et al. Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest 82 9 (2002) 1183-1192
52. Yang L., Scott P.G., Dodd C., et al. Identification of fibrocytes in postburn hypertrophic scar. Wound Repair Regen 13 4 (2005) 398-404
53. Bucala R., Spiegel L.A., Chesney J., et al. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1 1 (1994) 71-81
54. Chesney J., and Bucala R. Peripheral blood fibrocytes: novel fibroblast-like cells that present antigen and mediate tissue repair. Biochem Soc Trans 25 2 (1997) 520-524
55. Quan T.E., Cowper S., Wu S.P., et al. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 36 4 (2004) 598-606
56. Abe R., Donnelly S.C., Peng T., et al. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 166 12 (2001) 7556-7562
57. Metz C.N. Fibrocytes: a unique cell population implicated in wound healing. Cell Mol Life Sci 60 7 (2003) 1342-1350
58. Mori L., Bellini A., Stacey M.A., et al. Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp Cell Res 304 1 (2005) 81-90
59. Wang J., Jiao H., Stewart T.L., et al. Increased severity of bleomycin-induced skin fibrosis in mice with leukocyte-specific protein 1 deficiency. J Invest Dermatol 128 12 (2008) 2767-2776
60. Wang J., Jiao H., Stewart T.L., et al. Accelerated wound healing in leukocyte-specific, protein 1-deficient mouse is associated with increased infiltration of leukocytes and fibrocytes. J Leukoc Biol 82 6 (2007) 1554-1563
61. Sorrell J.M., Baber M.A., and Caplan A.I. Site-matched papillary and reticular human dermal fibroblasts differ in their release of specific growth factors/cytokines and in their interaction with keratinocytes. J Cell Physiol 200 1 (2004) 134-145
62. Azzarone B., and Macieira-Coelho A. Heterogeneity of the kinetics of proliferation within human skin fibroblastic cell populations. J Cell Sci 57 (1982) 177-187
63. Schafer I.A., Pandy M., Ferguson R., et al. Comparative observation of fibroblasts derived from the papillary and reticular dermis of infants and adults: growth kinetics, packing density at confluence and surface morphology. Mech Ageing Dev 31 3 (1985) 275-293
64. Ali-Bahar M., Bauer B., Tredget E.E., et al. Dermal fibroblasts from different layers of human skin are heterogeneous in expression of collagenase and types I and III procollagen mRNA. Wound Repair Regen 12 2 (2004) 175-182
65. Wang J., Dodd C., Shankowsky H.A., et al. Deep dermal fibroblasts contribute to hypertrophic scarring. Lab Invest 88 12 (2008) 1278-1290
66. Dunkin C.S., Pleat J.M., Gillespie P.H., et al. Scarring occurs at a critical depth of skin injury: precise measurement in a graduated dermal scratch in human volunteers. Plast Reconstr Surg 119 6 (2007) 1722-1732 [discussion: 33-4]
67. Heimbach D., Engrav L., Grube B., et al. Burn depth: a review. World J Surg 16 1 (1992) 10-15
68. Mladick R., Georgiade N., and Thorne F. A clinical evaluation of the use of thermography in determining degree of burn injury. Plast Reconstr Surg 38 6 (1966) 512-518
69. Cole R.P., Jones S.G., and Shakespeare P.G. Thermographic assessment of hand burns. Burns 16 1 (1990) 60-63
70. Droog E.J., Steenbergen W., and Sjoberg F. Measurement of depth of burns by laser Doppler perfusion imaging. Burns 27 6 (2001) 561-568
71. Smits G.J., Roman R.J., and Lombard J.H. Evaluation of laser Doppler flowmetry as a measure of tissue blood flow. J Appl Physiol 61 2 (1986) 666-672
72. Bray R., Forrester K., Leonard C., et al. Laser Doppler imaging of burn scars: a comparison of wavelength and scanning methods. Burns 29 3 (2003) 199-206
73. Niazi Z.B., Essex T.J., Papini R., et al. New laser Doppler scanner, a valuable adjunct in burn depth assessment. Burns 19 6 (1993) 485-489
74. Hoeksema H., Van de Sijpe K., Tondu T., et al. Accuracy of early burn depth assessment by laser Doppler imaging on different days post-burn. Burns 35 1 (2009) 36-45
75. Reno F., Grazianetti P., Stella M., et al. Release and activation of matrix metalloproteinase-9 during in vitro mechanical compression in hypertrophic scars. Arch Dermatol 138 4 (2002) 475-478
76. Costa A.M., Peyrol S., Porto L.C., et al. Mechanical forces induce scar remodeling. Study in nonpressure-treated versus pressure-treated hypertrophic scars. Am J Pathol 155 5 (1999) 1671-1679
77. Anzarut A., Olson J., Singh P., et al. The effectiveness of pressure garment therapy for the prevention of abnormal scarring after burn injury: a meta-analysis. J Plast Reconstr Aesthet Surg 62 1 (2009) 77-84
78. Borgognoni L. Biological effects of silicone gel sheeting. Wound Repair Regen 10 2 (2002) 118-121
79. So K., Umraw N., Scott J., et al. Effects of enhanced patient education on compliance with silicone gel sheeting and burn scar outcome: a randomized prospective study. J Burn Care Rehabil 24 6 (2003) 411-417 [discussion: 0]
80. Gilman T.H. Silicone sheet for treatment and prevention of hypertrophic scar: a new proposal for the mechanism of efficacy. Wound Repair Regen 11 3 (2003) 235-236
81. Lee T.Y., Chin G.S., Kim W.J., et al. Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids. Ann Plast Surg 43 2 (1999) 179-184
82. Kuhn M.A., Moffit M.R., Smith P.D., et al. Silicone sheeting decreases fibroblast activity and down-regulates TGFbeta2 in hypertrophic scar model. Int J Surg Investig 2 6 (2001) 467-474
83. Onoguchi K., Yoneyama M., Takemura A., et al. Viral infections activate types I and III interferon genes through a common mechanism. J Biol Chem 282 10 (2007) 7576-7581
84. Tredget E.E., Wang R., Shen Q., et al. Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: antagonism by IFN-alpha and IFN-gamma in vitro and in vivo. J Interferon Cytokine Res 20 2 (2000) 143-151
85. Wang J., Chen H., Shankowsky H.A., et al. Improved scar in postburn patients following interferon-alpha2b treatment is associated with decreased angiogenesis mediated by vascular endothelial cell growth factor. J Interferon Cytokine Res 28 7 (2008) 423-434
86. Wong T.W., Chiu H.C., and Yip K.M. Intralesional interferon alpha-2b has no effect in the treatment of keloids. Br J Dermatol 130 5 (1994) 683-685
87. Berman B., Viera M.H., Amini S., et al. Prevention and management of hypertrophic scars and keloids after burns in children. J Craniofac Surg 19 4 (2008) 989-1006
88. Poynard T., Colombo M., Bruix J., et al. Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon-alfa/ribavirin therapy. Gastroenterology 136 5 (2009) 1618-1628
89. Yang Y.F., Zhao W., Zhong Y.D., et al. Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: a meta-analysis. J Viral Hepat 16 4 (2009) 265-271
90. Tredget E.E., Adewale A.J., Matthey S., et al. A double-blind placebo-controlled trial using subcutaneous Intron A for the treatment of hypertophic scarring. [abstract]. Can J Plast Surg (2008) 116